Aceragen
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations (NCT05641298) | Aceragen | 2023-02-10 |
Track Aceragen automatically
Every clearance here is in the API, with alerts when new ones post.